|
U.S. Steel Corp., down $1.15 at $28.73 The steelmaker is selling its Serbian subsidiary to the government there for $1 and will record a charge of up to $450 million. Nasdaq Amylin Pharmaceuticals Inc., up $2.12 at $14.26 The FDA last week approved the drug developer's diabetes treatment Bydureon, which requires fewer injections that an older drug. Renren Inc., up $1.06 at $6.31 The Chinese social networking website got a boost from reports that Facebook will soon file for an initial public offering.
Copyright 2012 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor